Marek David C 4
4 · Myovant Sciences Ltd. · Filed Jan 20, 2023
Insider Transaction Report
Form 4
Marek David C
DirectorPrincipal Executive Officer
Transactions
- Sale
Common Shares
2023-01-18$26.89/sh−8,037$216,115→ 417,599 total
Footnotes (1)
- [F1]Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.